OFIX Stock Overview
Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Orthofix Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.40 |
| 52 Week High | US$23.19 |
| 52 Week Low | US$12.26 |
| Beta | 0.85 |
| 1 Month Change | -36.38% |
| 3 Month Change | -31.49% |
| 1 Year Change | -35.52% |
| 3 Year Change | -59.87% |
| 5 Year Change | -77.90% |
| Change since IPO | 18.10% |
Recent News & Updates
Recent updates
Orthofix Medical (NASDAQ:OFIX) Is In A Good Position To Deliver On Growth Plans
Nov 01
Orthofix stock falls amid SeaSpine merger despite rise in prelim Q3 revenue
Oct 11Orthofix inks licensing deal with CGBio for bone graft product Novosis
Aug 02Estimating The Fair Value Of Orthofix Medical Inc. (NASDAQ:OFIX)
May 12Companies Like Orthofix Medical (NASDAQ:OFIX) Can Afford To Invest In Growth
Apr 21FDA clears Orthofix's Orthonext digital platform for pediatric orthopedic procedures
May 10Orthofix EPS beats by $0.15, beats on revenue
Apr 30If You Had Bought Orthofix Medical's (NASDAQ:OFIX) Shares Three Years Ago You Would Be Down 20%
Feb 08Shareholder Returns
| OFIX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -3.7% | -4.0% | -3.8% |
| 1Y | -35.5% | 6.8% | 15.1% |
Return vs Industry: OFIX underperformed the US Medical Equipment industry which returned 7.3% over the past year.
Return vs Market: OFIX underperformed the US Market which returned 16.8% over the past year.
Price Volatility
| OFIX volatility | |
|---|---|
| OFIX Average Weekly Movement | 10.6% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in US Market | 14.2% |
| 10% least volatile stocks in US Market | 2.6% |
Stable Share Price: OFIX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: OFIX's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,092 | Cathy Burzik | https://www.orthofix.com |
Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions.
Orthofix Medical Inc. Fundamentals Summary
| OFIX fundamental statistics | |
|---|---|
| Market Cap | US$455.56m |
| Earnings (TTM) | -US$118.14m |
| Revenue (TTM) | US$598.45m |
0.8x
P/S Ratio-3.9x
P/E RatioIs OFIX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OFIX income statement (TTM) | |
|---|---|
| Revenue | US$598.45m |
| Cost of Revenue | US$174.87m |
| Gross Profit | US$423.58m |
| Other Expenses | US$541.72m |
| Earnings | -US$118.14m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.22 |
| Gross Margin | 70.78% |
| Net Profit Margin | -19.74% |
| Debt/Equity Ratio | 8.0% |
How did OFIX perform over the long term?
See historical performance and comparison